SUBSCRIBE
SUBSCRIBE
News   FDA

Zeltia Group’s Yondelis Approved in Russia for Sarcoma

November 25, 2008 | 
1 min read
MADRID, Nov 25 (Reuters) - Spanish biotech company Zeltia said on Tuesday that its partner Ortho Biotech Products has won approval to market its Yondelis cancer drug in Russia for the treatment of soft tissue sarcoma (STS) in adults.
FDA Approvals Europe
MORE ON THIS TOPIC
Podcast
MAHA Report Emphasizes Vaccines, Safety Vexes Viking’s Obesity Win, Novo Gains Momentum
August 20, 2025
 · 
2 min read
 · 
Heather McKenzie
Accumulated problems, contradictions. Dead end, we need to go back. You cannot continue further. Complete impossibility to continue. Rejection of an idea. Hard sanctions. Fatal error.
Rare diseases
FDA Rejects PTC Therapeutics’ Friedreich’s Ataxia Drug
August 19, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Time elapses in achieving the goal. Deadline. Get off schedule. Make it before the end of the term. Overdue work. Loss of relevance. Decrease in achievements, obsolescence of tasks.
Gene therapy
Regenxbio’s Hunter Syndrome Gene Therapy Hit With 3-Month PDUFA Delay
August 19, 2025
 · 
2 min read
 · 
Tristan Manalac
FDA
Leaked MAHA Strategy Emphasizes Vaccine Overhaul, Streamlined Access to Novel Therapies
August 18, 2025
 · 
3 min read
 · 
Heather McKenzie